Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Urinary and Tissue Proteomic Signatures Reveal Core and Progression Biomarkers in MRI-Visible and MRI-Non-Visible Prostate Cancer.

Life (Basel, Switzerland)·2026
Same author

Sarcomatoid urothelial carcinoma: advances and challenges.

Current opinion in urology·2026
Same author

Molecular pathology of bladder cancer.

Histopathology·2025
Same author

Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles.

European urology oncology·2025
Same author

Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer.

Pathobiology : journal of immunopathology, molecular and cellular biology·2025
Same author

Aberrant E-cadherin Expression in Lobular Carcinoma In Situ: A Comprehensive Immunohistochemical Evaluation of N-terminal, Extracellular, and C-terminal E-cadherin Domains.

The American journal of surgical pathology·2025

Related Experiment Video

Updated: Mar 2, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K

Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.

Ana Blanca1, Liang Cheng2, Rodolfo Montironi3

  • 1Maimonides Biomedical Research Institute of Cordoba, Spain, Cordoba. Spain.

Current Drug Metabolism
|May 20, 2017
PubMed
Summary
This summary is machine-generated.

MicroRNAs (miRNAs) show altered expression in bladder cancer (BC), impacting disease progression. Monitoring these miRNAs in bodily fluids offers potential for early diagnosis and targeted therapies.

Keywords:
Bladder cancerbiomarkerdiagnosisdisease monitoringmiRNAprognosis

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

11.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

11.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Over 3000 human microRNA (miRNA) sequences are known, but functions of most remain undetermined.
  • Aberrant miRNA expression is linked to cancer progression, including differentiation, invasion, and metastasis.
  • miRNAs regulate gene expression by targeting messenger transcripts, acting as oncogenes or tumor suppressors.

Purpose of the Study:

  • To review the relationship between miRNA expression and Bladder Cancer (BC).
  • To explore the potential of miRNAs as biomarkers for BC diagnosis and prognosis.

Main Methods:

  • Comprehensive literature review on miRNA expression in Bladder Cancer.
  • Analysis of differential miRNA expression in malignant versus normal tissues.
  • Evaluation of miRNA levels in urine and blood samples from BC patients.

Main Results:

  • miRNA expression profiles differ significantly between malignant and normal bladder tissues.
  • miRNAs are implicated as key drivers in Bladder Cancer progression.
  • Distinct miRNA levels in urine and blood suggest diagnostic potential for BC.

Conclusions:

  • Understanding miRNA mechanisms and distribution offers new avenues for BC diagnosis.
  • miRNAs present opportunities for prognostic assessment and disease monitoring in Bladder Cancer.
  • miRNA-based approaches may facilitate personalized therapy for Bladder Cancer patients.